DD238920A5 - Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung - Google Patents

Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung Download PDF

Info

Publication number
DD238920A5
DD238920A5 DD85281624A DD28162485A DD238920A5 DD 238920 A5 DD238920 A5 DD 238920A5 DD 85281624 A DD85281624 A DD 85281624A DD 28162485 A DD28162485 A DD 28162485A DD 238920 A5 DD238920 A5 DD 238920A5
Authority
DD
German Democratic Republic
Prior art keywords
piroxicam
pharmaceutically acceptable
acceptable salts
acetaminophen
doxepin
Prior art date
Application number
DD85281624A
Other languages
German (de)
English (en)
Inventor
Thomas Ch Crawford
Stanley L Keely
David L Larson
Joseph G Lombardino
James J Maciejko
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD238920A5 publication Critical patent/DD238920A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD85281624A 1984-10-11 1985-10-10 Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung DD238920A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65960284A 1984-10-11 1984-10-11

Publications (1)

Publication Number Publication Date
DD238920A5 true DD238920A5 (de) 1986-09-10

Family

ID=24646022

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85281624A DD238920A5 (de) 1984-10-11 1985-10-10 Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung

Country Status (5)

Country Link
US (2) US4564614A (ja)
JP (1) JPS6191124A (ja)
DD (1) DD238920A5 (ja)
HU (1) HU195110B (ja)
ZA (1) ZA857784B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
IT1241088B (it) * 1990-03-27 1993-12-29 Chiesi Farma Spa Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche
IT1262953B (it) * 1992-03-12 1996-07-23 Depalmo Galli Composizione a base di ibuprofen per uso orale.
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
GB9820746D0 (en) * 1998-09-23 1998-11-18 Pharmax Limited Micronised pharmaceutical compositions
PT1627639E (pt) * 2001-06-19 2010-03-01 Norbert Mueller Utilização de inibidores da cox-2 para o tratamento de distúrbios afectivos
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
DOP2007000055A (es) * 2006-04-10 2007-10-31 Senosiain S A De C V Lab Composición farmaceutica que comprende un analgésico y vitaminas
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
US20130109655A1 (en) * 2011-10-31 2013-05-02 Serghei Gargaun Method for mitigating of Prostaglandin E2 reducing side effects of non-steroidal anti-inflammatory drugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1083044A (en) * 1976-05-04 1980-08-05 Stewart Wong Antiarthritic potentiation
US4242353A (en) * 1978-12-18 1980-12-30 Mcneilab, Inc. Analgesic potentiation
US4207340A (en) * 1978-12-18 1980-06-10 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233313A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
EP0109281A1 (en) * 1982-11-15 1984-05-23 The Upjohn Company Compositions comprising flurbiprofen or ibuprofen

Also Published As

Publication number Publication date
HUT38540A (en) 1986-06-30
JPH0428245B2 (ja) 1992-05-13
JPS6191124A (ja) 1986-05-09
HU195110B (en) 1988-04-28
US4579846A (en) 1986-04-01
ZA857784B (en) 1987-05-27
US4564614A (en) 1986-01-14

Similar Documents

Publication Publication Date Title
DE3915347C2 (de) Harzadsorbate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE69329810T2 (de) Geschmacksmaskierte Arzneimittel enthaltend bittere Verbindungen
DE3874917T2 (de) Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
DE68905096T2 (de) Niacin und guar-mehl enthaltende zusammensetzung.
DE69109286T2 (de) Pharmazeutische zusammensetzung.
DE3650488T2 (de) Verwendung eines Tetrahydrocarbazolonderivates zur Herstellung von Arzneimitteln
DE69011766T2 (de) Wässerige Arzneisuspension für im wesentlichen wasserunlösliche Arzneiwirkstoffe.
DE3115086A1 (de) "dextromethorphan enthaltende pharamzeutische zusammensetzung und die verwendung von dextromethorphan zur schmerzbekaempfung"
DE69224684T2 (de) Verbesserte und dosierte orale Formulierungen von Dideoxypurinenukleosiden
EP0467164A2 (de) Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen
AT401468B (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DD238920A5 (de) Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung
EP0339420A2 (de) DHP-Retard-Zubereitung
DE3603564A1 (de) Pharmazeutische praeparate mit analgetrischer wirksamkeit, sowie deren herstellung und verwendung
DE69205158T2 (de) Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.
EP1140082A1 (de) Kombination von cerivastatin und fibraten
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
DE60013466T2 (de) Im mund zerfallende zusammensetzung mit mirtazapin
DE3517820A1 (de) Pharmazeutische praeparate mit antihypertensiver und kardioprotektiver wirkung
DE3602577A1 (de) 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DD242749A5 (de) Verbesserte entzuendungshemmende zusammensetzungen und verfahren
DE2700085A1 (de) Arzneimittel
DE60309582T2 (de) Verfahren zur herstellung einer einen antiretroviralen proteasehemmer enthaltenden pharmazeutischen zusammensetzung mit verbesserter bioverfügbarkeit

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee